Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition of Faeth Therapeutics and a concurrent $200 million private placement. The company’s lead program is now PIKTOR, an all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. This new […]
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
360last 24h
2369last 7d
427● bullish (7d)
220● bearish (7d)
202publishers
Insider Monkey98d agoneutral
Sensei Biotherapeutics (SNSE): Best Performing NASDAQ Stocks According to Wall Street AnalystsPharmaceutical Technology284d agoneutral
Sensei to ditch its lead candidate and cut workforce amidst strategic reviewThe Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.